Amgen Inc.
AMGN.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 35.49B | 35.15B | 34.50B | 33.51B | 32.78B |
| Total Other Revenue | 1.73B | 1.60B | 1.47B | 1.41B | 1.35B |
| Total Revenue | 37.22B | 36.75B | 35.97B | 34.92B | 34.13B |
| Cost of Revenue | 10.59B | 10.70B | 10.73B | 10.64B | 10.54B |
| Gross Profit | 26.63B | 26.05B | 25.24B | 24.28B | 23.58B |
| SG&A Expenses | 6.97B | 7.05B | 6.98B | 6.88B | 6.98B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -34.00M | 109.00M | 199.00M | 341.00M | 146.00M |
| Total Operating Expenses | 25.03B | 25.13B | 24.76B | 24.26B | 23.77B |
| Operating Income | 12.20B | 11.62B | 11.21B | 10.65B | 10.36B |
| Income Before Tax | 9.09B | 8.98B | 8.24B | 7.42B | 6.65B |
| Income Tax Expenses | 1.29B | 1.27B | 1.24B | 805.00M | 717.00M |
| Earnings from Continuing Operations | 7.80K | 7.71K | 7.01K | 6.62K | 5.93K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.80B | 7.71B | 7.01B | 6.62B | 5.93B |
| EBIT | 12.20B | 11.62B | 11.21B | 10.65B | 10.36B |
| EBITDA | 16.97B | 16.67B | 16.53B | 16.06B | 15.83B |
| EPS Basic | 14.48 | 14.33 | 13.02 | 12.31 | 11.04 |
| Normalized Basic EPS | 11.57 | 10.36 | 9.68 | 8.90 | 8.30 |
| EPS Diluted | 14.38 | 14.24 | 12.94 | 12.23 | 10.96 |
| Normalized Diluted EPS | 11.49 | 10.29 | 9.62 | 8.83 | 8.24 |
| Average Basic Shares Outstanding | 2.16B | 2.15B | 2.15B | 2.15B | 2.15B |
| Average Diluted Shares Outstanding | 2.17B | 2.17B | 2.17B | 2.17B | 2.17B |
| Dividend Per Share | 9.66 | 9.52 | 9.39 | 9.26 | 9.13 |
| Payout Ratio | 66.71% | 66.45% | 72.03% | 75.15% | 82.64% |